- Home
- EPWK vs MTNB Comparison
EPWK vs MTNB Comparison
Compare EPWK & MTNB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EPWK
- MTNB
- Stock Information
- Founded
- EPWK 2011
- MTNB 2013
- Country
- EPWK China
- MTNB United States
- Employees
- EPWK N/A
- MTNB N/A
- Industry
- EPWK
- MTNB Biotechnology: Pharmaceutical Preparations
- Sector
- EPWK
- MTNB Health Care
- Exchange
- EPWK Nasdaq
- MTNB Nasdaq
- Market Cap
- EPWK 9.5M
- MTNB 7.9M
- IPO Year
- EPWK 2025
- MTNB N/A
- Fundamental
- Price
- EPWK $0.45
- MTNB $2.13
- Analyst Decision
- EPWK
- MTNB Hold
- Analyst Count
- EPWK 0
- MTNB 1
- Target Price
- EPWK N/A
- MTNB N/A
- AVG Volume (30 Days)
- EPWK 311.2K
- MTNB 1.4M
- Earning Date
- EPWK 05-27-2025
- MTNB 08-14-2025
- Dividend Yield
- EPWK N/A
- MTNB N/A
- EPS Growth
- EPWK N/A
- MTNB N/A
- EPS
- EPWK N/A
- MTNB N/A
- Revenue
- EPWK $20,164,008.00
- MTNB N/A
- Revenue This Year
- EPWK N/A
- MTNB N/A
- Revenue Next Year
- EPWK N/A
- MTNB N/A
- P/E Ratio
- EPWK N/A
- MTNB N/A
- Revenue Growth
- EPWK 10.25
- MTNB N/A
- 52 Week Low
- EPWK $0.41
- MTNB $0.47
- 52 Week High
- EPWK $26.00
- MTNB $5.41
- Technical
- Relative Strength Index (RSI)
- EPWK N/A
- MTNB 69.03
- Support Level
- EPWK N/A
- MTNB $1.66
- Resistance Level
- EPWK N/A
- MTNB $1.90
- Average True Range (ATR)
- EPWK 0.00
- MTNB 0.37
- MACD
- EPWK 0.00
- MTNB 0.07
- Stochastic Oscillator
- EPWK 0.00
- MTNB 57.12
About EPWK EPWK Holdings Ltd. Class A Ordinary Shares
EPWK Holdings Ltd create an innovative and efficient crowdsourcing platform to connect businesses with great talents. It operates online marketplace to enable businesses (buyers) and service providers (sellers) to find each other. The platform users consist of buyers who seek talents for their jobs and sellers who offer different talents and skills. The company derives revenue mainly comes from providing various value-added services for users on both supply and demand sides.
About MTNB Matinas Biopharma Holdings Inc.
Matinas BioPharma Holdings Inc is a clinical-stage biopharmaceutical company with a focus on identifying and developing novel pharmaceutical products. The firm's pipeline includes MAT2203, MAT2501, and others.